Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Microbial Fermentation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1240844C details a novel microbial hydroxylation process for statin intermediates using non-sporulating bacteria, offering superior scalability and purity for API manufacturing.
Patent CN103255191A reveals a high-purity Androstenedione synthesis route. Discover cost-effective biotransformation methods for scalable steroid intermediate production.
Patent CN101760495B reveals a bio-dehydrogenation method for steroid intermediates. Achieve higher yields and eliminate toxic selenium residues for cost-effective manufacturing.
Patent CN106520896B reveals one-step fermentation for 8DM. Enhances yield and reduces solvent use for reliable pharmaceutical intermediates supply chains.
Patent CN103343155B offers high-yield fermentation for steroid intermediates, reducing costs and improving supply chain reliability for pharmaceutical manufacturing.
Patent CN102617697A details a novel eplerenone synthesis from androstenedione. This report analyzes the cost reduction and supply chain advantages for pharmaceutical manufacturers.
High-yield microbial conversion method for D-chiro-inositol from myo-inositol. Scalable fermentation process offering cost reduction and supply reliability.
Patent CN1220695A details a microbial process for chiral aminoalcohols, offering a scalable alternative to chemical synthesis for carbocyclic nucleosides.
Patent CN1070686A details microbial nitrile hydration for high-purity amides. This method offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN1224697C reveals a novel microbial process for high-purity aminoalcohols, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102603769A reveals novel sulfur-chromones from Penicillium oxalicum with potent anticancer activity, offering scalable fermentation routes for pharmaceutical intermediates.
Patent CN106520890B reveals a novel two-phase fermentation method using Aspergillus ochraceus for efficient steroid dehydrogenation, offering significant cost reduction in API manufacturing.
Patent CN109811024B reveals a novel fermentation recycling method for A82846B, drastically improving yield and component ratios for cost-effective pharmaceutical manufacturing.
Patent CN1302116C reveals a novel enzymatic route for high-purity cyclopentene intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN105779555B details a one-step microbial conversion for prednisolone intermediates, offering significant cost reduction and supply chain efficiency for pharmaceutical manufacturers.
Novel patent CN109438540A enables cost-effective steroid synthesis. Reliable supply chain for high-purity pharmaceutical intermediates with scalable production.
Patent CN105624215B reveals a 7-step synthesis of calcipotriol from stigmasterol. This route offers significant cost reduction and scalability for vitamin D analog manufacturing.
Patent CN102206696A reveals a scalable microbial route for 11,17α-substituted pregna-1,4-diene-3,20-dione. Achieve >97% purity and reduced manufacturing costs.
Patent CN102816825A reveals a novel microbial fermentation route for DHEA from plant sterols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.